Awakn Bristol

Awakn Bristol was a UK specialist mental health clinic and healthcare operating company within the Awakn Life Sciences group, best known for operating Awakn Clinics Bristol, one of the first medical psychedelic-assisted psychotherapy clinics in the UK. The Bristol business provided ketamine-assisted psychotherapy and related psychiatric services for addiction and mood disorders, and served as a clinical delivery site connected to Awakn's broader psychedelic therapeutics strategy. Legally, the entity was incorporated as Awakn Bristol Limited and had previously traded as Mandala Therapy Limited. Although the clinic operation was part of a broader biotech ecosystem around Awakn Life Sciences, the Bristol entity itself functioned primarily as a healthcare service provider rather than a standalone drug-development biotech company. As of 2026, the Companies House record shows the company in liquidation, and the broader Awakn parent was acquired by Solvonis Therapeutics in May 2025.